Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

  
Pipeline Graphic		  
 
New Releases

Thursday, December 22, 2011 | Anacor Pharmaceuticals Completes Enrollment in Second of Two Phase 3 Trials of Tavaborole for Onychomycosis
Monday, December 12, 2011 | Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase 2a Trial of AN2728 and AN2898 in Atopic Dermatitis
Thursday, November 10, 2011 | Anacor Pharmaceuticals Reports Third Quarter 2011 Financial Results
 
New Releases Graphic		  
 
Scientific Presentations

October 23-27, 2011 - Washington, DC

American Association of Pharmaceutical Sciences Annual Meeting

October 16-20, 2011 - Atlanta, Georgia

International Society for the Study of Xenobiotics

September 17-20, 2011 - Chicago, IL

51st ICAAC

September 7-10, 2011 - Barcelona, Spain

41st Annual Meeting of the European Society for Dermatological Research

May 7, 2011 - Milan, Italy

21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

May 5, 2011 - Phoenix, AZ

71st SID Annual Meeting
 

SITEMAP | CONTACT | PRIVACY POLICY | TERMS OF USE | HOME

  
 

© 2011 Anacor Pharmaceuticals, Inc., All Rights Reserved.